LEGALIZE POT? LOOK AT THESE STUDIES AND PICK WHAT YOU WANT TO BELIEVE

SACRAMENTO, Calif. -- Sparked anew by Gov. Arnold Schwarzenegger's
call for the state to study the legalization of marijuana, both sides
in the smoldering debate point to research to bolster their positions.

Such recitation of conflicting marijuana studies can be manipulated
and selected buffet-style to serve whatever political and health
agenda is being touted.

Even governmental findings can be contradictory. In 1999, for
instance, the Office of National Drug Control Policy asked the
Institute of Medicine to review evidence. The institute found that,
"except for the harms associated with smoking, the adverse effects of
marijuana use are within the range of effects tolerated for other
medications." Yet in 2006, the Food and Drug Administration ruled
that marijuana has no health benefits and has known and proven harms.
It is classified a Schedule 1 drug -- the highest risk of addiction
- -- in the Controlled Substances Act.

Wading through the medical literature, though, makes those
conclusions less cut-and-dried.

"When I was a resident ... in San Francisco in 1978, I gave a lecture
to physicians on marijuana, and I remember my conclusion at that time
was that you can find in the literature whatever you were looking
for," says Dr. Donald Abrams, a University of California-San
Francisco, oncologist and leading medical marijuana researcher. "
'Marijuana is good for asthma.' 'Marijuana's bad for asthma.'
'Marijuana causes schizophrenia.' 'Marijuana (decreases)
schizophrenia.' And, you know, the evidence is still like that," he said.

There are many factors, of course. As noted by UCLA pulmonologist Dr.
Donald Tashkin, who has studied marijuana's effects on the lungs for
three decades, "That's just the nature of medical science. You have
to deal with variability. The population studied may be different or
the methods used to study may differ."

Here is a look at the research on marijuana's effect in areas
critical to health:

Lungs

Tashkin studied heavy marijuana smokers to determine whether the use
led to increased risk of lung cancer and chronic obstructive
pulmonary disease. He had hypothesized that there would be a
definitive link between cancer and marijuana smoking, yet the results
proved otherwise.

"What we found instead was no association and even a suggestion of
some protective effect," says Tashkin, whose research was the largest
case-control study ever conducted. The study was funded by the
National Institutes of Health.

Tobacco smokers in the study had as much as a 21-fold increase in
lung-cancer risk. Cigarette smokers, too, developed COPD more often
in the study, and researchers found that marijuana did not impair
lung function.

Tashkin, supported by other research, concluded that the active
ingredient tetrahydrocannabinol, or THC, has an "anti-tumoral effect"
in which "cells die earlier before they age enough to develop
mutations that might lead to lung cancer." However, the smoke from
marijuana did swell the airways and lead to a greater risk of chronic
bronchitis.

Cognitive function

A 2006 study in the journal Neurology found that speed of thinking,
attention and verbal fluency were affected as much as 70 percent by
long-term heavy use (four or more joints per week).

But a 2003 review of literature in the Journal of the International
Neuropsychological Society found pot smoking had a "small effect" on
memory in longtime users. But users had no lasting effects in
reaction time, attention or verbal function.

"Surprisingly, we saw very little evidence of deleterious effects,"
Dr. Igor Grant, researcher at the University of California-San Diego
school of medicine, said in a statement.

Other studies: A 2002 study in the Journal of the American Medical
Association found that heavy users did worse on recall memory tests.
A 2006 study in Greece showed users had slower mental-processing
speed than the control group.

Then again, a 2007 study at the University of Lausanne in
Switzerland, published in Archives of Pediatrics & Adolescent
Medicine, found that students who smoked marijuana had better grades
than those who used only tobacco or those who did not smoke any substance.

In terms of brain development, a 2000 study in the Journal of
Addictive Diseases found changes in brain structure in those who
started using marijuana before age 17 but not in those who started at
an older age.

A 2009 Children's Hospital of Philadelphia study used brain imaging
to show that heavy adolescent users are more likely to have disrupted
brain development in regions involving memory, attention,
decision-making and language.

But a 2008 Ohio State University study found marijuana can reduce
brain inflammation and perhaps reduce memory impairment, which could
delay Alzheimer's disease.

Psychosis

There is an increased risk in psychotic behavior and long-term risk
of mental illness from marijuana use, according to a 2007 review of
literature commissioned by Great Britain's Department of Health and
published in the Lancet.

Depression

A study published in 2001 in the American Journal of Psychiatry
followed nearly 2,000 adults over 15 years. It found that marijuana
users who had no symptoms of depression at the start were four times
more likely than non-users to develop symptoms during that time frame.

In 2008, the U.S. Office of National Drug Control Policy stated that
early marijuana use could increase the likelihood of mental illness
by as much as 40 percent later in life. But researchers at McGill
University in Montreal in 2007 reported that THC in low doses
actually serves as an antidepressant similar to Prozac. At higher
doses, however, they found it could lead not only to depression but
also to psychotic episodes.